Declaration of Final Dividend of Rs 4/- per equity share of Rs. 10 each for the financial year ended March 31, 2026.
DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 2.4 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr Agarwal's Eye Hospital reported FY2026 results with Revenue from Operations growing 18.6% to ₹470.87 Cr from ₹397.15 Cr in FY2025. Net Profit after Tax surged 28.3% to ₹70.10 Cr from ₹54.65 Cr. Basic EPS stands at ₹147.02 vs ₹116.28 prior year. The Board recommended a final dividend of Rs 4 per share (40%), which combined with the interim dividend of Rs 3 already paid earlier in the year makes total dividend of Rs 7 per share (70%). The company also completed a ₹70 Cr preferential issue to its holding company during the year. S.R. Batliboi & Associates LLP issued an unmodified opinion on the audited results.
Strong financial performance with PAT growth exceeding 25% and robust dividend payout signals healthy earnings and cash generation. The stock should be viewed positively given consistent profitability and shareholder returns.